Related Experiment Video
Updated: Oct 18, 2025

06:48
CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
7.1K
Down, but Not Out: A Role for SMARCB1 in Synovial Sarcoma
Matthew B Maxwell1,2, Diana C Hargreaves3
1Biological Sciences Graduate Program, University of California, San Diego, La Jolla, California.
Cancer Discovery
|October 2, 2021
Summary
Reduced expression of the BAF complex tumor suppressor SMARCB1 plays a key role in synovial sarcoma development. This study reveals SMARCB1 reduction is caused by the degradation of BAF complexes in SS18-SSX2 fusion-driven cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Reduced protein expression of the BAF complex tumor suppressor SMARCB1 is common in synovial sarcoma.
- Synovial sarcoma is driven by the SS18-SSX fusion oncogene, which interferes with BAF complex function.
- The precise role of SMARCB1 reduction in sarcomagenesis remains unclear.
Purpose of the Study:
- To investigate the functional role of low-expressed SMARCB1 in synovial sarcoma development.
- To elucidate the mechanism behind SMARCB1 reduction in synovial sarcoma.
- To explore potential therapeutic strategies targeting the BAF complex in synovial sarcoma.
Main Methods:
- Utilized mouse models expressing the SS18-SSX2 fusion oncogene.
- Analyzed protein expression levels of SMARCB1 and BAF complex components.
- Investigated the degradation pathways of canonical BAF complexes.
Main Results:
- Demonstrated that reduced SMARCB1 has a functional role in SS18-SSX2-driven synovial sarcomagenesis.
- Provided evidence that SMARCB1 reduction results from the wholesale degradation of canonical BAF complexes.
- Identified a mechanism linking SS18-SSX fusion to BAF complex instability.
Conclusions:
- Low SMARCB1 expression is not merely a marker but actively contributes to synovial sarcoma formation.
- The degradation of BAF complexes is a key event in the pathogenesis of SS18-SSX driven synovial sarcoma.
- Targeting BAF complex stability may represent a novel therapeutic approach for synovial sarcoma.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.6K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Retinoblastoma Gene
4.3K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K

